The family of myotubularin-related proteins (Mtmrs) respectively, 
Introduction

The family of myotubularin-related proteins (Mtmrs) consists of 14 members in human beings and orthologues have been found in all eukaryotes but not in bacteria. Mutations in three family members are associated with human diseases. Mutations in myotubularin, the founding member of the Mtmr family, lead to X-linked myotubular myopathy
. X-linked myotubular myopathy is a severe muscle disease characterized by hypotonia and generalized muscle weakness in affected newborn males. Histopathological studies of the skeletal muscle in these patients reveal the presence of small rounded muscle fibres that contain centrally located nuclei. Since these fibres resemble foetal myotubes, it was proposed that the terminal differentiation of the muscle fibre is blocked [2] . [3] [4] [5] .
Mutations in MTMR2 or MTMR13/SBF2 lead to Charcot-MarieTooth (CMT) diseases type 4B1 or CMT4B2, respectively. These recessive peripheral neuropathies are clinically indistinguishable and are characterized by focally folded myelin sheets and demyelination in peripheral nerves
The Mtmr proteins are defined by a phosphoinositide-binding GRAM-pleckstrin homology domain (GRAM-PH), a phosphatase domain and a coiled coil. Active members dephosphorylate PI-3-P
to phosphatidylinositol and PI-3,5-P2 to PI-5-P. Although initially described as a protein tyrosine/dual specificity phosphatase based on the primary sequence, no phosphoprotein has been identified as substrate so far [6] . Mtmr2,  [7] . Interestingly, six of the 14 members have substitutions in the catalytic site of the phosphatase domain rendering them inactive. Several inactive myotubularins interact with active Mtmrs [8] . Alternatively, inactive Mtmrs can also exist independently within cells [9, 10] [20, 21] . PI-3-P and PI-3,5-P2, the substrates of Mtmr2, localize mainly to the endosomal compartment pointing to a function in protein trafficking, sorting and degradation. PI-3,5-P2 is produced from PI-3-P by PIKfyve, an enzyme that is found on early and late endosomes [22, 23] . It is transiently formed after the stimulation of cells with different treatments [24] [25] [26] . Several effector proteins including Mtmrs, sorting nexins (SNX), Svp1p and vps24 can bind to PI-3,5-P2 with low affinity and specificity [27] [28] [29] . Depending on the bound effector, the cargo of the corresponding vesicle is either directed to the lysosome or to the trans-Golgi network [30, 31] .
an active member of the family, is a 73 kD protein that exists as a dimer in eukaryotic cells. It contains a C-terminal Post-synaptic density protein-95, Drosophila disc large tumour suppressor, and Zonula occludens-1 protein (PDZ) binding motif in addition to the standard Mtmr domains. The GRAM-PH domain binds to several phosphoinositides and thereby mediates membrane binding
This report is based on the observation that the overexpression of myotubularin blocks the degradation of the epidermal growth factor receptor (EGFR) [26] 
Materials and methods
Plasmids and cell lines
The previously described His-tagged Mtmr2 and HA-tagged Sbf2 cDNAs were transferred from pcDNA3.1 zeo(ϩ) into pcDNA5/FRT [10] 
Transgenic mice
Animal experiments were approved by the veterinary office of the Canton of Zurich. The generation and genotyping of Mtmr2 and Mtmr13/Sbf2 knockout mice was described previously [32, 33] . Sciatic nerves from three adult animals (P60) were pooled, powdered in liquid nitrogen, and then lysed in 0.5% Triton-X100, 100 mM NaCl, 50 mM Tris-HCl pH 7.5. Twenty micrograms protein was used for Western blot analysis as described above. (Fig. 2) . This is in line with the finding that overexpression of Mtmrs does not induce vacuoles under resting condition, a phenotype previously described for a dominant negative form of PIKfyve (K1831E), an inhibitor of fluid phase uptake [10, 34] .
Results
Influence of Mtmr overexpression on receptor trafficking and fluid phase endocytosis
Colocalization with sorting nexins
SNX are a family of proteins which bind to receptor tyrosine kinases and phosphoinositides [35] . [30, 36, 37] (Fig. 3) . (Fig. 4) (Fig. 1) . [38] . How our data integrate with the critical role of Akt in this tissue remains to be elucidated. [24] [25] [26] 39] [10, 26] [41, 42] . Vps24 is part of the ESCRT-III complex and one of these adaptors [29] . Previous studies revealed that the knockdown of vps24 with RNAi or the overexpression of dominant-negative forms of vps24 block the degradation of the EGFR [43, 44] [37] . Consequently, reduction of PI-3,5-P2 levels and the production of PI-5-P are both possible explanations for the observed block in EGFR degradation. It is therefore reasonable to propose that the phosphatase activity of Mtmrs block downstream pathways depending on PI-3,5-P2 and redirects receptors to pathways depending on PI-5-P (Fig. 6) [45] . The generation of PI-5-P from PI-4,5-P2 seems to be a widespread mechanism of pathogenic bacteria to activate the Akt pathway to increase survival of host cells [46] . [50] [51] [52] . Future studies may elucidate which disease-associated proteins play a role in this pathway leading to peripheral neuropathies (reviewed in [53, 54] ).
. Mtmrs and SNX show a diffuse cytoplasmic, vesicular or plasma membrane staining under resting conditions (Fig. S2). Cells were stimulated with EGF and analysed after 30 min. when the EGFR passes the endosomal compartment and when PI-3,5-P2 peaks [26]. The cells respond at this time-point with an enlargement of endosomes allowing an accurate colocalization analysis. Mtmrs are able to colocalize with SNX suggesting that they influence sorting of receptors by modulating the phosphoinositide composition of membranes
Influence on downstream signalling
Stimulation of the EGFR leads to a transient activation of the Akt and Erk pathways. We wanted to test if the blocked degradation has consequences on signal output by the EGFR. We observed a transient phosphorylation of Akt, Erk1 and Erk2 in wild-type FlpIn293 cells after 20 and 40 min.
These findings suggest that sustained Akt activity is not simply due to the lack of EGFR degradation but due to specific sorting. If Mtmr2 is overexpressed with a form of Mtmr13/Sbf2 which lacks the C-terminal PI-3,4,5-P3 binding pleckstrin homology domain, phospho-Akt returns to basal level after 180 min. similar to wildtype cells. We conclude that sustained Akt activation is only achieved when Mtmr2 phosphatase activity and the PI-3,4,5-P3-binding pleckstrin homology domain of Mtmr13/Sbf2 are available.
Signalling in knockout animals
We were also interested if the observed in vitro influence of Mtmr2 overexpression on Akt signalling is relevant in vivo. For this purpose, we used our previously described Mtmr2 and Mtmr13/Sbf2 knockout animals that, in contrast to the acute stimulation experiments described so far, reflect a steady state condition. These animals show a similar but milder pathology than human beings affected with CMT 4B1 or CMT 4B2 [32, 33]. The sciatic nerves of these animals were analysed because the peripheral nervous system is the only affected tissue identified so far. We expected a down-regulation of phospho-Akt in mice lacking both Mtmr2 and Mtmr13/Sbf2 since Mtmr2 overexpression leads to sustained Akt activation. Indeed a reduction of the steady state ratio of phospho Akt to total Akt was observed in the mutant. The total level of phospho-Akt in mutant animals, however, is comparable to the levels in wild-type animals while the level of total Akt is significantly increased (Fig. 5). Mutant mice therefore appear to compensate for the inefficient phosphorylation of Akt by up-regulating the total level of this kinase. Neither total-Erk nor phospho-Erk differed between wild-type and mutant mice. Akt is a complex regulator of peripheral nerve development and function
Discussion
Mtmrs play a crucial role in human health and disease. Active family members dephosphorylate PI-3-P and PI-3,5-P2 in vitro and in vivo, but the consequences for the phosphoinositide-regulated cellular processes are poorly understood. We have overexpressed Mtmr2 to negatively regulate the levels of these two phosphoinositides in vivo. A more specific regulation is not possible since there is no mutant Mtmr2 available which specifically
dephosphorylates only one of the two substrates. Thus, whether PI-3-P or PI-3,5-P2 or both are the relevant substrates in vivo cannot be distinguished. Whereas the level of PI-3-P is high within cells, the level of PI-3,5-P2 is low under resting conditions and increases transiently after stimulation of cells
. The observation that Mtmr2 relocalizes within cells under conditions with elevated PI-3,5-P2 levels, e.g. under hypoosmotic conditions or after EGFR stimulation, point to PI-3,5-P2 as an important in vivo substrate
. In addition, one might speculate that the binding pocket for the D5 phosphate would have been closed during evolution if the activity towards PI-3,5-P2 is not necessary in vivo. This has been partially achieved in vitro with the artificial mutation H357N in Mtmr2 which reduces the activity towards PI-3,5-P2 but not towards PI-3-P [40].
Mtmr2 and Mtmr13/Sbf2 can acquire three different structural states in vitro and in vivo which affect the signalling of cell in different ways: (i) as a Mtmr2 dimer, (ii) as a Mtmr13/Sbf2 dimer and (iii) as a Mtmr2// Mtmr13/Sbf2 heterotetramer. Our results indicate, that the concentration, ratios and localization of these two Mtmrs have an important impact in which compartments the receptors are guided. Overexpression of Mtmr2 blocks the degradation of EGFR. Since this effect depends on phosphatase activity, it can either result from (i) the dephosphorylation of PI-3-P to phosphatidylinositol (ii) the dephosphorylation of PI-3,5-P2 or (iii) the production of PI-5-P. PI-3,5-P2 is produced in the endosomal compartment and assembles protein complexes for the trafficking into other subcellular locations of the cell
. PI-3,5-P2 is therefore an important metabolite for the degradation of the EGFR and PI-3,5-P2 dephosphorylation by Mtmr2 is one of the ways to interfere with EGFR degradation. PI-5-P is the least characterized phosphoinositide. SNX5 has a PX domain that binds PI-5-P. Interestingly, overexpression of SNX5 prevents the degradation of the EGFR indicating that it guides the EGFR away from lysosomes
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